Patrick Dumont
- Co-authors
- Ghanem AtassiYvan de LaunoitJacques H. PoupaertFrançois FuksM. VandendrisDidier MontéChristine DecaesteckerFranck Ladam
- Topics
- Lung Cancer Treatments and Mutations (12 papers)Lung Cancer Diagnosis and Treatment (9 papers)Cancer therapeutics and mechanisms (7 papers)
- Partner nations
- FranceBelgiumUnited Kingdom
In The Last Decade
Patrick Dumont
68 papers receiving 793 citations
Peers
Comparison fields: 5 of 108
- Molecular Biology 365
- Oncology 287
- Pulmonary and Respiratory Medicine 162
- Cancer Research 118
- Immunology 104
Countries citing papers authored by Patrick Dumont
This map shows the geographic impact of Patrick Dumont's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick Dumont with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick Dumont more than expected).
Fields of papers citing papers by Patrick Dumont
This network shows the impact of papers produced by Patrick Dumont. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick Dumont. The network helps show where Patrick Dumont may publish in the future.
Co-authorship network of co-authors of Patrick Dumont
This figure shows the co-authorship network connecting the top 25 collaborators of Patrick Dumont. A scholar is included among the top collaborators of Patrick Dumont based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patrick Dumont. Patrick Dumont is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 0 | |
| 3 | 25 | |
| 4 | 19 | |
| 5 | 21 | |
| 6 | 12 | |
| 7 | 6 | |
| 8 | 0 | |
| 9 | 44 | |
| 10 | 37 | |
| 11 | UNBS5162: a novel naphthalimide derivative with potent pro-autophagic effects in human cancer cells. | 1 |
| 12 | UNBS3157, a new amonafide derivative with improved in vivo efficacy and decreased toxicity | 2 |
| 13 | 49 | |
| 14 | 12 | |
| 15 | 27 | |
| 16 | 4 | |
| 17 | 21 | |
| 18 | 27 | |
| 19 | 18 | |
| 20 | 5 |
About Patrick Dumont
Patrick Dumont is a scholar working on Oncology, Behavioral Neuroscience and Pulmonary and Respiratory Medicine, having authored 72 papers that have together received 818 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (12 papers), Lung Cancer Diagnosis and Treatment (9 papers) and Cancer therapeutics and mechanisms (7 papers). The work is most often cited by research in Oncology (287 citations), Cancer Research (118 citations) and Behavioral Neuroscience (25 citations). Patrick Dumont has collaborated with scholars based in France, Belgium and United Kingdom. Frequent co-authors include Ghanem Atassi, Yvan de Launoit, Jacques H. Poupaert, François Fuks, M. Vandendris, Didier Monté, Christine Decaestecker, Franck Ladam, Anne Chotteau‐Lelièvre and Louis Kanarek. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE and The Science of The Total Environment.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.